As an immune checkpoint receptor, CD96 has been extensively demonstrated to have biological functions in T cells and natural killer cells53, playing an essential role in immunotherapy and the poor prognosis of many cancers, including hepatocellular carcinomas and gliomas54,55. The gene discussed is CD96; the disease is hepatocellular carcinoma.